- Home
- GRRR vs ABSI Comparison
GRRR vs ABSI Comparison
Compare GRRR & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- ABSI
- Stock Information
- Founded
- GRRR 2001
- ABSI 2011
- Country
- GRRR United Kingdom
- ABSI United States
- Employees
- GRRR N/A
- ABSI N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- GRRR Technology
- ABSI Health Care
- Exchange
- GRRR Nasdaq
- ABSI Nasdaq
- Market Cap
- GRRR 312.8M
- ABSI 353.8M
- IPO Year
- GRRR N/A
- ABSI 2021
- Fundamental
- Price
- GRRR $16.13
- ABSI $2.75
- Analyst Decision
- GRRR Buy
- ABSI Strong Buy
- Analyst Count
- GRRR 1
- ABSI 5
- Target Price
- GRRR $18.00
- ABSI $8.40
- AVG Volume (30 Days)
- GRRR 1.4M
- ABSI 2.5M
- Earning Date
- GRRR 03-31-2025
- ABSI 05-13-2025
- Dividend Yield
- GRRR N/A
- ABSI N/A
- EPS Growth
- GRRR N/A
- ABSI N/A
- EPS
- GRRR N/A
- ABSI N/A
- Revenue
- GRRR $74,674,030.00
- ABSI $4,534,000.00
- Revenue This Year
- GRRR $36.59
- ABSI $158.58
- Revenue Next Year
- GRRR $30.68
- ABSI $93.12
- P/E Ratio
- GRRR N/A
- ABSI N/A
- Revenue Growth
- GRRR 15.43
- ABSI N/A
- 52 Week Low
- GRRR $2.09
- ABSI $2.01
- 52 Week High
- GRRR $44.15
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- GRRR 42.71
- ABSI 42.92
- Support Level
- GRRR $14.32
- ABSI $2.85
- Resistance Level
- GRRR $15.64
- ABSI $2.94
- Average True Range (ATR)
- GRRR 1.37
- ABSI 0.19
- MACD
- GRRR -0.06
- ABSI -0.03
- Stochastic Oscillator
- GRRR 27.55
- ABSI 14.13
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.